74500 Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices 

Participation in the IHS Scholarship 

Program,’’ Office of Management and 

Budget (OMB) Control No. 0917–0006. 

IHS is requesting OMB to approve an 

extension for this collection, which 

expires on October 31, 2023. 

DATES: Comment Due Date: November 

30, 2023. Your comments regarding this 

information collection are best assured 

of having full effect if received within 

30 days of the date of this publication. 

ADDRESSES: Send your comments and 

suggestions regarding the proposed 

information collection contained in this 

notice, especially regarding the 

estimated public burden and associated 

response time to: Office of Management 

and Budget, Office of Regulatory Affairs, 

New Executive Office Building, Room 

10235, Washington, DC 20503, 

Attention: Desk Officer for IHS. 

FOR FURTHER INFORMATION CONTACT: To 

request additional information, please 

contact Evonne Bennett, Information 

Collection Clearance Officer by email at: 

Evonne.Bennett@ihs.gov or telephone at 

240–472–1996. 

SUPPLEMENTARY INFORMATION: This 

previously approved information 

collection project was last published in 

the Federal Register (88 FR 59929), on 

August 30, 2023 and allowed 60 days 

for public comment. The purpose of this 

notice is to allow 30 days for public 

comment. A copy of the supporting 

statement is available at 

www.regulations.gov (see Docket ID 

IHS–2023–0001). 

Information Collection: Title: 

‘‘Application for Participation in the 

IHS Scholarship Program,’’ OMB 

Control No. 0917–0006. Type of 

Information Collection Request: 

Extension of the currently approved 

information collection ‘‘Application for 

Participation in the IHS Scholarship 

Program,’’ OMB Control No. 0917–0006. 

Form Number(s): IHS–856–07 through 

856–16, IHS–856–21 through 856–22, 

IHS–817, and IHS–818 are retained for 

use by the IHS Scholarship Program 

(IHSSP) as part of this current 

Information Collection Request. 

Reporting forms are found on the IHS 

website at www.ihs.gov/scholarship. 

Need and Use of Information Collection: 

The IHS Scholarship Branch needs this 

information for program administration 

and uses the information to: solicit, 

process, and award IHS Pre-graduate, 

Preparatory, and/or Health Professions 

Scholarship recipients; monitor the 

academic performance of recipients; and 

to place recipients at payback sites. The 

IHSSP application is electronically 

available on the internet at the IHS 

website at: http://www.ihs.gov/ 

scholarship/applynow/. Affected Public: 

Individuals, not-for-profit institutions 

and State, local or Tribal Governments. 

Type of Respondents: Students pursuing 

health care professions. 

The table below provides: Types of 

data collection instruments, Estimated 

number of respondents, Number of 

responses per respondent, Annual 

number of responses, Average burden 

hour per response, and Total annual 

burden hours. 

Forms Data collection instrument(s) Number of 

respondents 

Responses 

per 

respondent 

Total 

annual 

response 

Burden hour per 

response * 

Annual 

burden 

hours 

Scholarship Online Application ............................................. 850 1 850 1.00 (60 min) ........ 850 

1 .................. Verification of Acceptance or Decline of Award (IHS–856– 

7).

300 1 300 0.13 ( 8 min) ......... 40 

2 .................. Scholarship Program Agreement (IHS–817) ........................ 60 1 60 0.16 (10 min) ........ 10 

3 .................. Health Professions Contract (IHS–818) ............................... 225 1 225 0.16 (10min) ......... 38 

4 .................. Recipient’s Initial Program Progress Report (IHS–856–8) ... 800 1 800 0.13 (8 min) .......... 107 

5 .................. Notification of Academic Problem (IHS–856–9) ................... 20 1 20 0.13 (8 min) .......... 3 

6 .................. Change of Status (IHS–856–10) .......................................... 50 1 50 .045 (25 min) ........ 21 

7 .................. Notification of Deferment Intent (IHS–856–11) .................... 60 1 60 0.13 (8 min) .......... 8 

8 .................. Preferred Placement (IHS–856–12) ..................................... 150 1 150 0.50 (30 min) ........ 75 

9 .................. Notification of Impending Graduation (IHS–856–13) ............ 170 1 170 0.17 (10 min) ........ 28 

10 ................ Deferment Approval Request (IHS–856–14) ........................ 60 1 60 0.13 (8 min) .......... 8 

11 ................ Placement Update (IHS–856–15) ......................................... 170 1 170 0.18 (11 min) ........ 31 

12 ................ Annual Status Report (IHS–856–16) .................................... 200 1 200 0.25 (15 min) ........ 50 

13 ................ Summer School Request (IHS–856–21) .............................. 100 1 100 0.10 (6 min) .......... 10 

14 ................ Change of Name or Address (IHS–856–22) ........................ 20 1 20 0.13 (8 min) .......... 3 

Total ..... ............................................................................................... ........................ ........................ 3,235 225 ....................... 1,281 

* For ease of understanding, burden hours per response are also provided in minutes. 

There are no direct costs to 

respondents other than their time to 

voluntarily complete the forms and 

submit them for consideration. The 

estimated cost for the federal 

government is $145,223.00 (contractor) 

to work on the program with IHS 

program staff. 

There are no capital costs, operating 

costs and/or maintenance costs to 

respondents. 

Requests for Comments: Your written 

comments and/or suggestions are 

invited on one or more of the following 

points: 

(a) whether the information collection 

activity is necessary to carry out an 

agency function; 

(b) whether the agency processes the 

information collected in a useful and 

timely fashion; 

(c) the accuracy of the public burden 

estimate (the estimated amount of time 

needed for individual respondents to 

provide the requested information); 

(d) whether the methodology and 

assumptions used to determine the 

estimates are logical; 

(e) ways to enhance the quality, 

utility, and clarity of the information 

being collected; and 

(f) ways to minimize the public 

burden through the use of automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Roselyn Tso, 

Director, Indian Health Service. 

[FR Doc. 2023–23996 Filed 10–30–23; 8:45 am] 

BILLING CODE 4166–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices 74501 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics in Neurobehavioral 

Processes, Sleep, and Aging. 

Date: December 6, 2023. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kristen Prentice, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3112, 

MSC 7808, Bethesda, MD 20892, (301) 496– 

0726, prenticekj@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics on HIV Molecular Virology, 

Therapies and Comorbidities Study Section. 

Date: December 6, 2023. 

Time: 11:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Raul Rojas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6185, 

Bethesda, MD 20892, (301) 451–6319, rojasr@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 26, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–24005 Filed 10–30–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel CuttingEdge Basic Research Awards (CEBRA). 

Date: November 20, 2023. 

Time: 10:00 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sheila Pirooznia, Ph.D., 

Scientific Review Officer, Division of 

Extramural Review, Scientific Review 

Branch, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 496–9350, 

sheila.pirooznia@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: October 25, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–23942 Filed 10–30–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council for Human Genome Research. 

This is a hybrid meeting held inperson and virtually and is open to the 

public as indicated below. Individuals 

who plan to attend in-person or view 

the virtual meeting and need special 

assistance or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. The meeting will be 

videocast and can be accessed from 

https://www.genome.gov/about-nhgri/ 

Institute-Advisors/National-AdvisoryCouncil-for-Human-Genome-Research. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Human Genome Research. 

Date: February 12–13, 2024. 

Closed: February 12, 2024, 9:00 a.m. to 

10:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, Suite 1100, Bethesda, MD 

20892. 

Open: February 12, 2024, 10:30 a.m. to 6:30 

p.m. 

Agenda: Report of Institute Director and 

Institute Staff. 

Place: National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, Suite 1100, Bethesda, MD 

20892. 

Closed: February 13, 2024, 10:30 a.m. to 

5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, Suite 1100, Bethesda, MD 

20892. 

Contact Person: Rudy O. Pozzatti, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, 6700 B Rockledge Drive, Suite 

3100, Rockville, MD 20892, (301) 402–0838, 

pozzattr@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus Federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.genome.gov/council, where an agenda 


lotter on DSK11XQN23PROD with NOTICES1